Cardiac-specific VEGFB overexpression reduces lipoprotein lipase activity and improves insulin action in rat heart.
Shang R, Lal N, Lee CS, Zhai Y, Puri K, Seira O, Boushel RC, Sultan I, Räsänen M, Alitalo K, et al. Am J Physiol Endocrinol Metab. 2021 Dec 1; 321(6):E753-E765. Epub 2021 Nov 8.